Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advance Provision of COCs to Reduce Contraceptive Implant Discontinuation
NCT04828824Phase 4Completed
- Sponsor
- University of Colorado Denver
- Start
- Jun 2021
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of norgestimate + ethinyl estradiol in contraception, sponsored by University of Colorado Denver. Started Jun 2021; status: completed.
02
Drugs
norgestimate + ethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT04828824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04828824.